Bank of New York Mellon’s SQZ Biotechnologies Company SQZ Stock Holding History

Bank of New York Mellon’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-71,440	Closed	-$343K	–	4739
2022 Q1	$343K	Sell	71,440 -2,424	-3%	-$15.4K	﹤0.01%	3939
2021 Q4	$660K	Buy	73,864 +4,670	+7%	+$57.2K	﹤0.01%	3627
2021 Q3	$998K	Buy	69,194 +8,181	+13%	+$111K	﹤0.01%	3394
2021 Q2	$881K	Buy	61,013 +47,792	+361%	+$624K	﹤0.01%	3498
2021 Q1	$180K	Sell	13,221 -1,201	-8%	-$24.4K	﹤0.01%	4083
2020 Q4	$418K	Buy	+14,422	New	+$368K	﹤0.01%	3702

Other funds holding SQZ

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon's SQZ Position: Q2 2022 in Review

Bank of New York Mellon sold out of SQZ Biotechnologies Company (SQZ) in Q2 2022, closing a stake of 71,440 shares — an estimated $343K sold.

Bank of New York Mellon first reported a position in SQZ in Q4 2020 and held it in 6 quarters. The position peaked at $998K in Q3 2021. 53 funds tracked by Wall St. Rank hold SQZ as of Q2 2022.

Bank of New York Mellon reported no remaining SQZ Biotechnologies Company position as of Q2 2022 after selling out during the quarter.
Bank of New York Mellon sold 71,440 SQZ Biotechnologies Company shares in Q2 2022, an estimated $343K.
Bank of New York Mellon first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 6 quarters.
Bank of New York Mellon's SQZ Biotechnologies Company position peaked at $998K in Q3 2021.
53 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q2 2022.

Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.